The effects of age on carbamazepine pharmacokinetics and adverse effects
- PMID: 3567018
- PMCID: PMC1401196
- DOI: 10.1111/j.1365-2125.1986.tb02965.x
The effects of age on carbamazepine pharmacokinetics and adverse effects
Abstract
The pharmacokinetics and effect of single oral doses of carbamazepine (400 mg) were compared in a group of six young volunteers aged between 20 and 25 years, and a second group of five elderly volunteers aged between 66 and 84 years. No age related changes in salivary or plasma pharmacokinetics or in psychomotor function were detected.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
